Neogen Corp. NEOG
Other disclosure
Regulation FD material, other events or exhibits only; no item that askFlo treats as material.
Other / needs reviewImportance: LowRejected
NEOGEN CORP
NEOGUSNasdaqHealthcareIn Vitro & In Vivo Diagnostic Substances
Investment brief
Create a free account to read 3 full briefs a month: verdict, strengths, risks, how you could invest and what the price implies. No card needed.
Founding members
The first 100 accounts get 3 months free
98 of 100 free places left · 2 taken
Create your account and get full access for 3 months — no card, no automatic charge. After that it is 20 € a month, only if you choose to continue.
Create a free accountAlready have an account? Sign in
Neogen Corp. NEOG
Regulation FD material, other events or exhibits only; no item that askFlo treats as material.
Other / needs reviewImportance: LowRejected
Neogen Corp. NEOG
Changes to bylaws, shareholder rights or votes; most are administrative.
GovernanceImportance: LowVerified in filing
Annual figures as reported in each year's 10-K (calendar-aligned years). Operating margin is computed in code as operating income divided by revenue.
This company is not in the rankings (they cover companies with at least USD 1 bn in revenue).
Figures for CY2025 (period ending 2026-05-31) from SEC EDGAR XBRL. A dash (—) means the company did not report the figure in a comparable form. These lists rank companies by reported figures. A high rank is a fact about the numbers, not a recommendation to buy, sell or hold, and not personalised advice. Past results do not predict future returns.
Ask Flo about any company or market
Ask Flo is included in the subscription.
Talk to us
Questions about the service, your subscription or an invoice? Write to us:
WhatsApp · +40 770 709 449 E-mail · hello@purceas.com